Directory
>
Kelly Buteas
Kelly Buteas
Senior Audit Associate | Bristol Myers Squibb
New Jersey, Morristown, United States
Kelly Buteas
Summary
Kelly Buteas is an accomplished executive with extensive experience in the pharmaceutical industry, currently serving as the Executive Director for Worldwide Commercialization Analytics at Bristol Myers Squibb. With a strong background in strategic planning and business analysis, she has played pivotal roles in cell therapy and hematology projects. Kelly's career trajectory includes significant positions at Celgene and BD, where she honed her skills in internal audit and financial planning. She holds an MBA in Strategy & Leadership from Rutgers Business School and a B.S. in Accounting from The College of New Jersey. Kelly is known for her analytical prowess and leadership in driving commercialization strategies. Her expertise extends to forecasting and planning for innovative therapies, positioning her as a key player in the evolving landscape of oncology. Outside of her professional endeavors, she is passionate about mentoring future leaders in the industry.
Kelly Buteas
Work Experience
Executive Director - Worldwide Commercialization Analytics Cell Therapy Lead at
Bristol Myers Squibb
March 2024 - Present
Kelly Buteas
Education
Rutgers Business School – Newark and New Brunswick, Master of Business Administration (MBA), Strategy & Leadership
The College of New Jersey, Bachelor of Science (B.S.), Accounting
January 2002 - January 2006
Frequently Asked Questions about Kelly Buteas
What is Kelly Buteas email address?
Kelly Buteas's primary email address is ************@bms.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kelly Buteas work for?
Kelly Buteas is a Senior Audit Associate at Bristol Myers Squibb.
Where Kelly Buteas graduated from?
Kelly Buteas holds a degree in null from Rutgers Business School – Newark and New Brunswick.
How can I directly contact Kelly Buteas?
To contact Kelly Buteas directly, you can use the email address ************@bms.com. Complete contact information is available upon registration with Muraena.
Who is Kelly Buteas?
Kelly Buteas is an accomplished executive with extensive experience in the pharmaceutical industry, currently serving as the Executive Director for Worldwide Commercialization Analytics at Bristol Myers Squibb. With a strong background in strategic planning and business analysis, she has played pivotal roles in cell therapy and hematology projects. Kelly's career trajectory includes significant positions at Celgene and BD, where she honed her skills in internal audit and financial planning. She holds an MBA in Strategy & Leadership from Rutgers Business School and a B.S. in Accounting from The College of New Jersey. Kelly is known for her analytical prowess and leadership in driving commercialization strategies. Her expertise extends to forecasting and planning for innovative therapies, positioning her as a key player in the evolving landscape of oncology. Outside of her professional endeavors, she is passionate about mentoring future leaders in the industry.
Kelly`s contact details
************@bms.com
Colleagues
QC Lab Technician
General Practitioner
Scientist, Operations
Junior Research Fellow
stagiair
Vice President Corporate Development, Head of M&A
Postdoctoral Fellow
Attorney
Laboratory Technician
Executive Director, Head of Regulatory Information and Submission Management